Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1438Pancreatic Neoplasms 862Carcinoma, Hepatocellular 745Stomach Neoplasms 650Colonic Neoplasms 448Rectal Neoplasms 406Esophageal Neoplasms 400Breast Neoplasms 332Carcinoma, Non-Small-Cell Lung 328Neoplasms 307Liver Neoplasms 283Cholangiocarcinoma 244Ovarian Neoplasms 243Lung Neoplasms 239Neoplasm Metastasis 237Gastrointestinal Neoplasms 219Melanoma 186Esophageal Squamous Cell Carcinoma 167Prostatic Neoplasms 166Biliary Tract Neoplasms 161Endometrial Neoplasms 143Uterine Cervical Neoplasms 130Squamous Cell Carcinoma of Head and Neck 129Head and Neck Neoplasms 114Carcinoma, Renal Cell 114Sarcoma 101Urinary Bladder Neoplasms 97Adenocarcinoma Of Esophagus 90Triple Negative Breast Neoplasms 87Anus Neoplasms 83

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PRETEXT I Hepatoblastoma × Gastrointestinal × 1 year × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡